Review the interrelated role of cardiometabolic risk factors, including obesity, dyslipidemia, and diabetes, in the global pandemic of cardiovascular disease.
Results of the ACT II study suggest that the investigational antiarrhythmic may help almost half of all patients who develop atrial fibrillation or flutter after CABG or valve surgery. Heartwire
This important Effective Health Care Report from AHRQ compares ACEIs and ARBs: Is there a difference? Agency for Healthcare Research and Quality (AHRQ)
"Patients with systolic heart failure in NYHA class 2 should be treated with aldosterone antagonists." Or should they? The issue was debated in Buenos Aires by two prominent specialists. Heartwire
